Fesoterodine
Links shared publicly online about this topic
Fesoterodine for OAB Shows Efficacy at One Week - Renal and Urology News
renalandurologynews.com — “In a recent study, fesoterodine showed rapid onset of efficacy at one week in patients with overactive bladder (OAB) who were previously treated with tolterodine and dissatisfied with that drug.” View full resource at renalandurologynews.com
Most Recently Shared on October 18, 2010 at 5:17 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Fesoterodine for OAB Shows Efficacy at One Week: In a recent study, fesoterodine showed rapid onset of efficacy at... http://bit.ly/cTEbER
Early onset of fesoterodine efficacy in subjects with overactive bladder - Goldman - 2010 - BJU International - Wiley Online Library
onlinelibrary.wiley.com — “Early onset of fesoterodine efficacy in subjects with overactive bladder - Goldman - 2010 - BJU International - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on September 25, 2010 at 6:23 pm By:
Urology & Nephrology OW Health
Early onset of fesoterodine efficacy in subjects with overactive bladder: Study Type – Therapy (cohort)
Level ... http://bit.ly/csAiDh
Toviaz 8 Mg Was More Effective Than Detrol LA In Treating Urge Urinary Incontinence In Patients With Overactive Bladder
medicalnewstoday.com — “Patients treated with Toviaz® (fesoterodine fumarate) 8 mg extended release tablets had greater and statistically significant reductions in urge urinary incontinence episodes at week 12 (P=0.0” View full resource at medicalnewstoday.com
Most Recently Shared on December 17, 2009 at 5:38 pm By:
Toviaz 8 Mg Was More Effective Than Detrol LA In Treating Urge Urinary Incontinence In Patients With Overactive Bladd.. http://bit.ly/66pzNk
Urology Article - Urinary Bladder
mdlinx.com — “Efficacy and Tolerability of Fesoterodine in Older and Younger Subjects With Overactive Bladder” View full resource at mdlinx.com
Most Recently Shared on October 30, 2010 at 2:40 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and Tolerability of Fesoterodine in Older and Younger Subjects With Overactive Bladder: Urology http://bit.ly/b9EYD7 #urology
Top-line primary endpoint data from Pfizer's Toviaz trial on overactive bladder
news-medical.net — “Pfizer Inc. announced today the top-line primary endpoint result for Toviaz (fesoterodine fumarate) Study A0221049 - Efficacy and Safety of Fesoterodine Flexible Dose Regimen in Vulnerable Elderly Patients with Overactive Bladder.” View full resource at news-medical.net
Most Recently Shared on December 6, 2011 at 8:51 am By:
Urology & Nephrology OW Health
Top-line primary endpoint data from Pfizer's Toviaz trial on overactive bladder: Pfizer Inc. announced today the... http://t.co/Mbqfm2Cm
Toviaz Top-Line Primary Endpoint Results Positive In Overactive Bladder Study Of Nocturnal Urinary Urgency | Business Wire
businesswire.com — “Pfizer Inc. (NYSE: PFE) announced today top-line results for Toviaz (fesoterodine fumarate) Study A0221048 – Effectiveness and Safety of a Flexi” View full resource at businesswire.com
Most Recently Shared on November 8, 2011 at 3:04 pm By:
Toviaz Top-Line Primary Endpoint Results Positive In Overactive Bladder Study Of Nocturnal Urinary Urgency: NEW ... http://t.co/Q2q1hVP0
Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients | Business Wire
businesswire.com — “Pfizer Inc. (NYSE: PFE) announced today the top-line primary endpoint result for Toviaz (fesoterodine fumarate) Study A0221049 – Efficacy and Sa” View full resource at businesswire.com
Most Recently Shared on December 6, 2011 at 2:49 am By:
Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Eld... http://t.co/Mn0GIk9d
Pfizer's Toviaz Study A0221048 for overactive bladder meets primary endpoint
news-medical.net — “Pfizer Inc. announced today top-line results for Toviaz (fesoterodine fumarate) Study A0221048 - Effectiveness and Safety of a Flexible Dose Regimen for Patients with Overactive Bladder including Nocturnal Urinary Urgency.” View full resource at news-medical.net
Most Recently Shared on November 9, 2011 at 9:52 am By:
Pfizer's Toviaz Study A0221048 for overactive bladder meets primary endpoint: Pfizer Inc. announced today top-li... http://t.co/ZO1euza8
Urology News & Articles - MDLinx - Urinary Bladder on #MDlinx
mdlinx.com — “Urology News & Articles - MDLinx - Urinary Bladder on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on September 26, 2010 at 6:38 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Patient-optimized doses of fesoterodine improve bladder symptoms in an open-label, flexible-dose study: BJ... http://bit.ly/bQodi0 #urology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Renal Urology News
Renal and Urology News reports on clinical news for both nephrologists and urologists.
-
Urology & Nephrology
Organizing urology resources shared by health experts, advocates, and organizations into WisdomCards.
-
medical_tweets
Advertisement
